Basic Science News at Duke School of Medicine

The North Carolina American Society for Microbiology (NC-ASM) annual meeting, hosted by the Duke Microbiome Center, attracted more than 300 researchers from across the Southeast.

Using a technique that has shown promise in targeting cancer tumors, a Duke team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.

The Duke Nuclear Magnetic Resonance spectroscopy (NMR) Center provides seven "state-of-the-art, multi-million-dollar instruments where researchers can run their experiments for very affordable fees.

Immunologist Jose R. Conejo-Garcia, MD, PhD, unveils an antibody that successfully targets once-untreatable KRAS cancer mutations.

Duke scholars are studying how hallucinogenic drugs might become alternative treatments for medical-resistant conditions.

Everardo Macias's quest to find innovative treatments for prostate cancer mirrors his own incredible journey – from a migrant farm worker to a groundbreaking scientist.

Immunologists identify a pivotal protein in the progression of MS. Could blocking it be the future of treatment?

When Felicia Pagliuca arrived at Duke as a first-year undergraduate student from Asheville, she was only 16, but she was already fascinated by biology and physics. She knew she wanted to do scientific research “someday.”

The National Institutes of Health (NIH) has awarded grants to two Duke University School of Medicine faculty members through the NIH Common Fund’s High-Risk, High-Reward (HRHR) Research Program. 

Doug Marchuk, PhD, James B. Duke Distinguished Professor of Molecular Genetics and Microbiology, and Aravind Asokan, PhD, professor in surgery, have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).